Source link : https://newshealth.biz/health-news/perioperative-nivolumab-does-not-sacrifice-qol-in-nsclc/
Perioperative nivolumab in eligible patients with resectable non-small cell lung cancer offers improved survival outcomes and preserves quality of life, new data show. Medscape Medical News Source link : https://www.medscape.com/viewarticle/perioperative-nivolumab-does-not-sacrifice-qol-nsclc-2025a1000nl9?src=rss Author : Publish date : 2025-09-07 15:31:00 Copyright for syndicated content belongs to the linked Source.
The post Perioperative Nivolumab Does Not Sacrifice QoL in NSCLC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-07 15:31:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8